A multicenter study in which the Germans Trias i Pujol University Hospital has participated on Wernicke's encephalopathy, a neurological disease associated with alcohol abuse, reveals a wide clinical...
The West Nile Fever (WNF), a zoonotic disease caused by West Nile Virus, has increased in Spain during the last years: the number of cases has quadrupled from 2022 to 2023. Researchers from the UAB take part in the innovative project...
Researchers at the UAB have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hypertension....
A pioneering UAB study reveals the fundamental role of secondary structures of encoding mRNA in the DNA damage detection machinery, which directs and stabilizes vital proteins in the response to genetic damage, such as p53. The findings suggest...
Errors in medicine obviously affect the patient, but also the professionals involved. Survey-based research in the field of cardiology has analyzed the experience of these professionals to shed light on the psychological...
In Catalonia, information is scarce about the in-hospital burden of diseases involving viral lower respiratory tract infections (bronchiolitis, bronchitis, asthma exacerbation and pneumonia) in paediatric population. A...
In 2014, a vaccination program for pregnant women against whooping cough began in Catalonia due to the increase in hospitalizations of young infants for...
The cardiovascular research group at the Germans Trias i Pujol Research Institute has developed a new strategy to regenerate cardiac scars caused by myocardial infarction. They are now studying whether this therapy, which reduces infarct...
During the 2017/2018 academic year, in the Module of Nursing and Medical Anthropology of the bachelor’s degree in Nursing at the UAB, workshops designed together with HIV patients were carried out to bring the...
The Nervous System Gene Therapy (UAB) research group and the VHIR Multiple Sclerosis Center of Catalonia are developing a gene therapy capable of reducing the inflammatory response in early and advanced stages of the disease. The results obtained in animal models are...
